摘要
根据多年中医药治疗高血压病的临床实践中遇到的类,归结为五大难题,即诊断难:诊断是确定病因病机及决定治疗措施的关键,但高血压病没有对应的中医病名,诊断无从下手;治疗难:辨证论治没有根据,治疗没有原则,使得证型无规律可循;疗效评价难:血压下降而症状可不消失,反之,症状消失血压可不下降,使中医疗效无法被人认可;科研设计难:中医临床优势与西医治疗优势不同,导致科研设计不严谨;成果推广难:辨证论治重复性低,中成药疗效不能肯定,导致高血压中医研究成果推广难。针对五大难题,提出了相应的处理措施,为高血压病的临床和中医科研开拓了思路。
In the authors view, there are five diffculties in the TCM therapeutics for hypertension according to his clinical practice for decades of years. Firstly, there is diffculty in diagnosis. Diagnosis play a key role in the decision of therapeutic strategy for a certain disease as well as to disclose its etiology and pathogenesis. While in TCM there is no corresponding normanation for hypertension resulting in the difficulty in diagnosis. Secondly, with no basis on bianzhenlunzhi and no principle on therapeutics, the clinicians have difficulty in finding regularities in zhenxing. Thirdly, there is difficulty in therapeutic evaluation. Symptoms may not disappear with the decrease of blood pressure, while disappearance of symptoms may be accompanied with no change in blood pressure. As a consequence, TCM efficacy can hardly be ad- mitted by public. Fourthly, there is difiqculty in research design. The differences in clinical advantages between TCM and medicine lead to the inaccuracy in research design. Lastly, there is difiqculty in product promotion. As it is hard to duplicate its bianzhenlunzhi , TCM efficacy can hardly be admitted by public. As a result, there is difficulty in the promotion of TCM research products on hypertension. To deal with these five difficulties, the author raised corresponding strategies for them and hence broaden the thoughts for TCM research as well as clinical practice in hypertension.
出处
《中华中医药学刊》
CAS
2008年第6期1137-1138,共2页
Chinese Archives of Traditional Chinese Medicine
关键词
高血压病
中医临床
难题与对策
Hypertension
TCM clinical practice
Difficulties and Strategy
